StockData
Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. (OTLK) stock

OTLKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/30
$0.41+0.05 (+13.12%)

Close on Nov 18, 2026Market cap $99.30MP/E –Yield –

Earnings

Outlook Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Dec 18, 2026
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$9.00K
-99.4% on a year earlier
adjusted net loss attributable to common stockholders, Q3 FY2026
$0.09
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Outlook Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Sep 30, 2026Dec 18, 2026Expected–––––
Q3 FY2026ended Jun 30, 2026Aug 14, 2026before the open$9.00K-99.4%$0.15$0.09Release
Q2 FY2026ended Mar 31, 2026May 18, 2026after the close$128.00K–$0.05$0.16Release
Q1 FY2026ended Dec 31, 2025Feb 17, 2026before the open-$1.21M–-$0.38-$0.22Release
Q4 FY2025ended Sep 30, 2025Dec 19, 2025before the open––––Release
Q3 FY2025ended Jun 30, 2025Aug 14, 2025after the close$1.50M–––Release
Q2 FY2025ended Mar 31, 2025May 15, 2025after the close––$1.50$0.40Release
Q1 FY2025ended Dec 31, 2024Feb 14, 2025before the open––$0.72-$0.89Release
Q4 FY2024ended Sep 30, 2024Dec 27, 2024before the open––––Release
Q3 FY2024ended Jun 30, 2024Aug 14, 2024before the open––-$0.89-$0.83Release
Q2 FY2024ended Mar 31, 2024May 15, 2024after the close––$8.01–Release
Q1 FY2024ended Dec 31, 2023Feb 14, 2024after the close––-$0.04–Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Outlook Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Outlook Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Outlook Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. News
  4. News
  5. News
  6. News
  7. Results
  8. News
  9. News
  10. News
  11. News
  12. Results
  13. News
  14. News
  15. Results

See a number that looks wrong?